Dr. Aman Dabir, MD

Dr. Dabir practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Dabir's NPI, 1164833281, was assigned on May 12, 2014. Dr. Dabir holds West Virginia license 27653.

Dr. Dabir's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Dabir's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Dabir is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Dr. Dabir to 6 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dabir practices, 9 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Dabir's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Dabir is licensed in West Virginia.

CMS data shows 287 Medicare services from Dr. Dabir across 9 procedure codes in 2024, for 213 Medicare patients. Medicare paid $23,443 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 213 Medicare patients who saw Dr. Dabir in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dabir's median patient age at 57, with 50% women.

In 2024, Dr. Dabir wrote 859 Medicare Part D claims for 92 patients. 77% of them were for generic drugs. CMS names the drug for 767 of them, across 21 drugs with 11 or more claims each, at $262,335 in total drug cost. In 2023, CMS named 615 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Dabir for performance year 2024, reported through an alternative payment model (APM). Dr. Dabir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dabir as offering telehealth.

CMS Open Payments shows 10 general payments to Dr. Dabir from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 58% of the total. LivaNova USA, Inc. paid the most, $500.